Bioequivalence of IMP 08P1707F0 Relative to Pulmicort® (1.0 Mg/2 Ml Suspension)
Clinical trial NCT06595121 · COMPLETED
Trial details
- NCT number
- NCT06595121
- Sponsor
- Unither Pharmaceuticals, France
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-13
- Primary completion
- 2024-09-16
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.